ACHE and diabetes mellitus: Numerous Boswellia terpenoid components have shown selective docking to bacterial protein targets, antineoplastic molecular targets, diabetes-relevant targets, protein targets involved in inflammatory disease conditions, and the Alzheimer’s disease target acetylcholinesterase.